In this episode of Medicine Redefined, Darsh and Altamash take a deep dive into the complex world of medications with Dr. Vinay Patel, pharmacist and founder of MakoRx. Dr. Patel exposes the hidden realities behind Big Pharma, explaining why generic drugs can be so confusing and revealing the true factors driving skyrocketing pharmacy prices. We also explore how cutting-edge AI technology is revolutionizing drug discovery and development.

This conversation will fundamentally change how you understand the medications you rely on every day. Whether you’re a healthcare professional or simply curious, this episode delivers powerful knowledge and a fresh perspective. Tune in!

TIMESTAMPS

00:00 Introduction to Medicine Redefined00:36 Meet Vinay Patel: Healthcare Innovator01:04 Understanding PBMs: The Hidden Middlemen02:47 The Evolution of PBMs05:29 Vertical Integration and Its Impact15:52 The Complexities of Drug Pricing26:30 Compounding Pharmacies and GLP-1 Medications34:15 Mark Cuban's Cost Plus Solution37:39 The Dominance of Employer-Based Health Insurance39:46 The Generic vs. Brand Medication Debate40:52 Challenges in Generic Drug Manufacturing45:05 The Role of Pharmacists in Medication Management50:50 Solutions for a Broken Healthcare System53:54 Introduction to Make O Rx58:29 Overcoming Barriers in the Healthcare Market01:01:31 The Future of Pharmaceuticals and AI01:05:54 Key Takeaways for Healthcare Providers01:08:04 Final Thoughts and Contact Information

SOURCES

00:19: Price We Pay Book
01:35: Pharmacy Benefit Management History
03:24: Medical Modernization Act
03:53: Affordable Care Act
04:13: Vertical Integration
04:33: Big Three Control 80% of Prescriptions
04:56: 20% of Smaller Companies
05:40: Tyson Foods RightWay
06:01: Smaller PBMs Gaining Traction
07:42: Antitrust enforcement in healthcare
08:22: Affordable Care Act and High Deductible Plans
09:24: Gag clauses
09:58: Trump’s Law to Eliminate Gag Clauses
10:39: Elizabeth Warren and Josh Hawley's Bill on PBMs
13:25: Clawbacks
14:32: Clawback disclosure law
14:52: Losing money on drugs
15:00: GLP-1 drugs
16:27: Info on drug pricing
17:05: Insurance companies set drug prices
22:01: Article on rebates
22:30: Net prices have gone down
22:39: List prices have gone up
24:21: Deep dive into drug prices in US
24:45: US VS Europe drug pricing
26:49: US subsidizes the world’s drug prices
27:32: History of Ozempic
28:31: Current status of Ozempic shortage
29:11: Compounding drugs law
32:21: Compounding pharmacy credit...